Who are CARGO Therapeutics's investors?

CARGO Therapeutics's investors include Nextech Invest, Red Tree Venture, Samsara BioCapital, Ally Bridge Group, Janus Henderson Investors, Perceptive Xontogeny Venture, Third Rock Ventures.

How much funding has CARGO Therapeutics raised?

CARGO Therapeutics has disclosed $68.8M raised across 1 round.

Where is CARGO Therapeutics headquartered?

CARGO Therapeutics is headquartered in San Mateo, US.

CARGO Therapeutics

San Mateo, US · Founded 2019 · Delaware corporation · 26 employees on LinkedIn · 7 known investors

Find your way into CARGO Therapeutics

Launched by Samsara in partnership with CAR T pioneers, advancing a clinically validated CD22 CAR T for lymphoma.

Biotech

Founders & leadership

Gina ChapmaninPresident & Chief Executive Officer2022–2025Gina Chapman is an executive with over 30 years of biopharma leadership experience across development, portfolio strategy, commercialization, business development, and operations at organizations ranging from startups to mature companies. She has served as CEO and Board Director, and recently led fundraising efforts including an IPO.

Anup RadhakrishnaninInterim Chief Executive Officer2025–2025

Cassandra Gianna LucaNamed on SEC filing

Jeffrey WalshNamed on SEC filing

Krishnan ViswanadhanNamed on SEC filing

Board

Abraham BassanBoard director

Crystal MackallBoard directorScientific Advisory Board - Oncology; Director, Stanford Center for Cancer Cell Therapy at Red Tree Venture

Heath LukatchBoard director

John OrwinBoard director

Investors · 7

Nextech InvestZurich · $648K – $3.2M

Red Tree VentureSan Diego

Samsara BioCapitalPalo Alto

Ally Bridge GroupreportedNew York

Janus Henderson InvestorsreportedLondon

Perceptive Xontogeny VenturereportedNew York

Third Rock VenturesreportedBoston · $100K – $5M

Reported raises · per SEC filings

Form D private placements

$68.8M disclosed across 1 round · 2023

▶$68.8MraisedMar 2023 · 19 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Gina ChapmanExecutive Officer, Director
Abraham BassanDirector
Cassandra Gianna LucaDirector
Jeffrey WalshDirector
Krishnan ViswanadhanDirector
Crystal MackallDirector
Heath LukatchDirector
John OrwinDirector
Anup RadhakrishnanExecutive Officer

Offering amount: $200.8M
Amount sold: $68.8M
First sale: Feb 2023
Incorporated: Corporation, Delaware, 2019
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Jefferies Raises Price Target for Cargo Therapeutics (CRGX), Keeps Hold Ratingfinance.yahoo.com · Jul 2025

CARGO Therapeutics Raises $200 Million in Oversubscribed, Upsized Series A Financing to Advance its Pipeline of Next Generation CAR T-Cell Therapiesglobenewswire.com · Mar 2023

Frequently asked questions

What does CARGO Therapeutics do?: Launched by Samsara in partnership with CAR T pioneers, advancing a clinically validated CD22 CAR T for lymphoma.
Who are CARGO Therapeutics's investors?: CARGO Therapeutics's investors include Nextech Invest, Red Tree Venture, Samsara BioCapital, Ally Bridge Group, Janus Henderson Investors, Perceptive Xontogeny Venture, Third Rock Ventures.
How much funding has CARGO Therapeutics raised?: CARGO Therapeutics has disclosed $68.8M raised across 1 round.
Where is CARGO Therapeutics headquartered?: CARGO Therapeutics is headquartered in San Mateo, US.